Incidence and Characteristic of Deep Venous Thrombosis in Hospitalized Chronic Heart Failure Patients

Overview

Journal Heart Vessels

Specialty Cardiology & Vascular Diseases

Date 2024 Mar 20

PMID 38507055

Authors

Jia-Lin Yuan

Wen Kang Xiao

Chao Qiong Zhang

Le Sun

Ying Kang Lin

Chuang-Xiong Hong

Affiliations

Soon will be listed here.

Abstract

Background: This study was conducted to investigate the incidence of deep venous thrombosis (DVT), outcomes and its characteristics in patients with chronic heart failure (CHF) in a retrospective setting.

Outcomes: Patients died of cardiac shock or acute exacerbation of heart failure (HF), admitted to intensive care unit (ICU) due to acute exacerbation of HF, patients decided to withdraw treatment and return home due to acute exacerbation of HF.

Methods: From January 2015 to June 2022, we admitted 359 patients diagnosed with CHF, and lower limb ultrasonography was performed for the examination of DVT after admission. The incidence of DVT was recorded and patients with known risk factors of VTE were identified and excluded after incidence of DVT was calculated. Patients' clinical data were then collected.

Results: The occurrence of DVT was 10.0% (36/359), as calf intramuscular vein thrombosis was the main constitution (n = 28, 75%). DVT patients with other factors (carcinoma, surgery, stroke, previous history of DVT) constituted a considerable part (33.3%, 12/36). Age, history of Diabetes Mellitus (DM), levels of DDi (D-Dimer), levels of alanine transferase (ALT) and left ventricular end-diastolic diameter (LVEDd) were independent predictors or risk factors of DVT in CHF patients, while chronic kidney disease (CKD) stage 1-4, white blood cell (WBC) and direct oral anticoagulant (DOAC) were protective factors. Incidence of DVT was correlated with a poor outcome of CHF patients (Pearson Chi-Square test, Value 19.612, P < 0.001).

Conclusions: In this retrospective study, incidence of DVT was found to be relatively high among hospitalized CHF patients, while patients with DVT was associated with a poor prognosis.

Citing Articles

Development and verification of a nomogram for predicting portal vein tumor thrombosis in hepatocellular carcinoma.

Liu G, Long J, Liu C, Chen J Am J Transl Res. 2025; 16(12):7511-7520.

PMID: 39822560 PMC: 11733390. DOI: 10.62347/PLQF5135.

References

Samama M . An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000; 160(22):3415-20. DOI: 10.1001/archinte.160.22.3415. View

Ng T, Tsai F, Khatri N, Barakat M, Elkayam U . Venous thromboembolism in hospitalized patients with heart failure: incidence, prognosis, and prevention. Circ Heart Fail. 2010; 3(1):165-73. DOI: 10.1161/CIRCHEARTFAILURE.109.892349. View

Alikhan R, Spyropoulos A . Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease. Am J Med. 2008; 121(11):935-42. DOI: 10.1016/j.amjmed.2008.05.045. View

JAFRI S . Hypercoagulability in heart failure. Semin Thromb Hemost. 1997; 23(6):543-5. DOI: 10.1055/s-2007-996133. View

Piazza G, Seddighzadeh A, Goldhaber S . Heart failure in patients with deep vein thrombosis. Am J Cardiol. 2008; 101(7):1056-9. DOI: 10.1016/j.amjcard.2007.11.051. View

Alikhan R, Cohen A, Combe S, Samama M, Desjardins L, Eldor A . Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis. 2003; 14(4):341-6. DOI: 10.1097/00001721-200306000-00004. View

Fanola C, Norby F, Shah A, Chang P, Lutsey P, Rosamond W . Incident Heart Failure and Long-Term Risk for Venous Thromboembolism. J Am Coll Cardiol. 2020; 75(2):148-158. PMC: 7262575. DOI: 10.1016/j.jacc.2019.10.058. View

Dries D, Rosenberg Y, Waclawiw M, Domanski M . Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol. 1997; 29(5):1074-80. DOI: 10.1016/s0735-1097(97)00019-3. View

Smilowitz N, Zhao Q, Wang L, Shrestha S, Baser O, Berger J . Risk of Venous Thromboembolism after New Onset Heart Failure. Sci Rep. 2019; 9(1):17415. PMC: 6874686. DOI: 10.1038/s41598-019-53641-0. View

10.

Melgaard L, Nielsen P, Overvad T, Skjoth F, Lip G, Larsen T . Sex differences in risk of incident venous thromboembolism in heart failure patients. Clin Res Cardiol. 2018; 108(1):101-109. DOI: 10.1007/s00392-018-1329-9. View

11.

Beemath A, Stein P, Skaf E, Al Sibae M, Alesh I . Risk of venous thromboembolism in patients hospitalized with heart failure. Am J Cardiol. 2006; 98(6):793-5. DOI: 10.1016/j.amjcard.2006.03.064. View

12.

Ota S, Yamada N, Tsuji A, Ishikura K, Nakamura M, Ito M . Incidence and clinical predictors of deep vein thrombosis in patients hospitalized with heart failure in Japan. Circ J. 2009; 73(8):1513-7. DOI: 10.1253/circj.cj-08-0990. View

13.

Darze E, Latado A, Guimaraes A, Guedes R, Santos A, de Moura S . Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit. Chest. 2005; 128(4):2576-80. DOI: 10.1378/chest.128.4.2576. View

14.

Tagalakis V, Patenaude V, Kahn S, Suissa S . Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med. 2013; 126(9):832.e13-21. DOI: 10.1016/j.amjmed.2013.02.024. View

15.

White R, Zhou H, Murin S, Harvey D . Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost. 2005; 93(2):298-305. DOI: 10.1160/TH04-08-0506. View

16.

McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36):3599-3726. DOI: 10.1093/eurheartj/ehab368. View

17.

Duncan D, Taddonio M, Chang E, Huang B . Characterization of intramuscular calf vein thrombosis on routine knee MRI. Skeletal Radiol. 2019; 48(10):1573-1580. DOI: 10.1007/s00256-019-03213-0. View

18.

Rose S, Zwiebel W, Miller F . Distribution of acute lower extremity deep venous thrombosis in symptomatic and asymptomatic patients: imaging implications. J Ultrasound Med. 1994; 13(4):243-50. DOI: 10.7863/jum.1994.13.4.243. View

19.

Tebbe U, Schellong S, Haas S, Gerlach H, Abletshauser C, Sieder C . Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY study. Am Heart J. 2011; 161(2):322-8. DOI: 10.1016/j.ahj.2010.10.005. View

20.

Cohen A, Davidson B, Gallus A, Lassen M, Prins M, Tomkowski W . Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006; 332(7537):325-9. PMC: 1363908. DOI: 10.1136/bmj.38733.466748.7C. View